Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval By: MarketWatch June 01, 2023 at 11:46 AM EDT Global market for RSV vaccine could reach $17 billion by 2033, analysts say. Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Moderna Inc Pfizer Sanofi-Aventis S.A. ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval By: MarketWatch June 01, 2023 at 11:46 AM EDT Global market for RSV vaccine could reach $17 billion by 2033, analysts say. Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Moderna Inc Pfizer Sanofi-Aventis S.A. ADR